New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
10:01 EDTORMPOramed falls 12.4%
Oramed is down 12.4%, or $2.73, to $19.36
News For ORMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
09:06 EDTORMPOramed privides update on studies in letter to shareholders
Subscribe for More Information
January 20, 2015
10:46 EDTORMPOramed management to meet with Roth Capital
Meeting to be held in New York on January 26 hosted by Roth Capital.
January 16, 2015
08:30 EDTORMPOramed granted patent in Israel for oral administration of GLP-1
Oramed announced that the Israel Patent Office has granted the Company's patent for its invention, titled "Methods and Compositions for Oral Administrations of Exenatide."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use